TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10401914

Group type: EXPERIMENTAL
Intervention: Lithium augmentation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 8583016

Group type: EXPERIMENTAL
Intervention: Self-assessment focused on gingival bleeding (group I)
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Self-assessment focused on plaque (group II)
Number of subjects: 493

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 493
Study: 2205290

Group type: EXPERIMENTAL
Intervention: 30 micrograms ethinyl oestradiol daily by mouth for 10 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo daily by mouth for 10 days
Number of subjects: 36
Study: 391094

Group type: EXPERIMENTAL
Intervention: N‐(3',4'‐dimethoxycinnamoyl) anthranilic acid (N‐5')
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (N0)
Number of subjects: 3
Study: 29712515

Group type: EXPERIMENTAL
Intervention: IV infusion of 30 IU of oxytocin started before uterine incision (Group I)
Number of subjects: 200

Group type: COMPARATOR
Intervention: IV infusion of 30 IU of oxytocin started after clamping the umbilical cord (Group II)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Group II (after clamping the umbilical cord)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Group I (before uterine incision)
Number of subjects: 200
Study: 27884081

Group type: EXPERIMENTAL
Intervention: Titratable mandibular advancement appliance (MAA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Non-titratable mandibular advancement appliance (MAA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both types of MAAs
Number of subjects: 12
Study: 24817063

Group type: EXPERIMENTAL
Intervention: HbA1c
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: ADDQoL
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Health status physical health summary score
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: HbA1c change
Number of subjects: 510
Study: 23636616

Group type: EXPERIMENTAL
Intervention: Nutritional supplements
Number of subjects: 35

Group type: COMPARATOR
Intervention: Healthy controls (CG)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Asthmatic children (AG) without supplements
Number of subjects: 35
Study: 21510853

Group type: COMPARATOR
Intervention: Background stroke care (limited, no thrombolytic therapy)
Number of subjects: 19435
Study: 19002467

Group type: EXPERIMENTAL
Intervention: Iso-osmolar contrast medium (IOCM, iodixanol)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Low-osmolar contrast media (LOCM, iopamidol and iomeprol)
Number of subjects: 301
Study: 17360872

Group type: EXPERIMENTAL
Intervention: malaria vaccine regimen FP9 ME‐TRAP/MVA ME‐TRAP
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: sulfadoxine‐pyrimethamine (SP)
Number of subjects: 102

Group type: COMPARATOR
Intervention: rabies vaccine
Number of subjects: 102
Study: 15030837

Group type: EXPERIMENTAL
Intervention: Honan intraocular pressure reducer (HIPR)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No compression
Number of subjects: 45
Study: 11157317

Group type: EXPERIMENTAL
Intervention: High isoflavone diet (132 +/- 22 mg isoflavones/d)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low isoflavone diet (65 +/- 11 mg isoflavones/d)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control diet (7.1 +/- 1.1 mg isoflavones/d)
Number of subjects: 18
Study: 9559237

Group type: EXPERIMENTAL
Intervention: Urban Integrated Service Agency (ISA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rural Integrated Service Agency (ISA)
Number of subjects: 0
Study: 7840430

Group type: EXPERIMENTAL
Intervention: Micro anion-exchange chromatography/enzyme immunoassay
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Commercial kit with ready-to-use microcolumns and radioimmunoassay
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control subjects (daily alcohol intake < 40 g)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Chronic ethylic subjects
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Patients suffering from non-alcoholic liver diseases
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Enzyme and radioimmunoassays
Number of subjects: 245
Study: 2628537

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adrenaline 0.01 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salbutamol 0.007 mg/kg
Number of subjects: 0
Study: 1018117

Group type: EXPERIMENTAL
Intervention: Vigilance orientation
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Avoidance orientation
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: No orientation
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Temporal uncertainty (knowing vs. not knowing when shock would occur)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Anticipation time (1, 3, or 12 minutes)
Number of subjects: 108
Study: 31823057

Group type: EXPERIMENTAL
Intervention: Brief Pain Inventory (BPI) intervention group
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Edmonton Symptom Assessment Scale (ESAS) intervention group
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Regular use of paracetamol, anti-neuropathic pain drugs, and opioids in the intervention group
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 264
Study: 30205020

Group type: EXPERIMENTAL
Intervention: Implants placed in group O (osteoporosis)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Implants placed in group C (control)
Number of subjects: 48
Study: 28039545

Group type: EXPERIMENTAL
Intervention: Mechanical debridement (MD) with enamel matrix derivative (EMD)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Mechanical debridement (MD) alone
Number of subjects: 46
Study: 25738212

Group type: EXPERIMENTAL
Intervention: Calcium plus Vitamin D3 (50,000 IU/wk)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Calcium placebo plus Vitamin D3 placebo
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg/d) plus Vitamin D3 placebo
Number of subjects: 118

Group type: COMPARATOR
Intervention: Vitamin D3 placebo plus Calcium placebo
Number of subjects: 118
Study: 23932192

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) in Early Exercise (EE) group
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) in Delayed Exercise (DE) group
Number of subjects: 41

Group type: COMPARATOR
Intervention: Self‐chosen physical activity in Early Exercise (EE) group
Number of subjects: 41

Group type: COMPARATOR
Intervention: Self‐chosen physical activity in Delayed Exercise (DE) group
Number of subjects: 41
Study: 21872439

Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 1019

Group type: COMPARATOR
Intervention: Non-statin treatment (Control)
Number of subjects: 1019
Study: 19570393

Group type: EXPERIMENTAL
Intervention: Insulin added into 'all in one' bags
Number of subjects: 20

Group type: COMPARATOR
Intervention: Insulin added into syringes and transfused by infusion pump
Number of subjects: 20
Study: 22381573

Group type: EXPERIMENTAL
Intervention: Unilateral PS instrumented TLIF
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bilateral PS instrumented TLIF
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (Unilateral and Bilateral PS)
Number of subjects: 80
Study: 15995106

Group type: EXPERIMENTAL
Intervention: Bacitracin solution (group B)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Castile soap solution (group C)
Number of subjects: 400
Study: 12821883

Group type: EXPERIMENTAL
Intervention: High-fat monounsaturated-fat-enriched diet (MUFA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: High-carbohydrate low-fat diet (HCLF)
Number of subjects: 13
Study: 10786507

Group type: EXPERIMENTAL
Intervention: Kinaesthetic infant handling (KIH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 8708198

Group type: EXPERIMENTAL
Intervention: CPN intervention
Number of subjects: 231

Group type: COMPARATOR
Intervention: Continuing general practitioner care
Number of subjects: 231
Study: 2247251

Group type: EXPERIMENTAL
Intervention: Propofol-O2/N2O
Number of subjects: 62

Group type: COMPARATOR
Intervention: Propofol-O2/air
Number of subjects: 62
Study: 95337

Group type: EXPERIMENTAL
Intervention: Apekumarol
Number of subjects: 143

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 143
Study: 11604622

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil solution for 5 minutes after excision
Number of subjects: 11

Group type: COMPARATOR
Intervention: Phosphate-buffered saline for 5 minutes after excision
Number of subjects: 11
Study: 30536413

Group type: EXPERIMENTAL
Intervention: Response-adaptive (RA) designs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CARA designs
Number of subjects: 0
Study: 29483080

Group type: EXPERIMENTAL
Intervention: Sirukumab 100 mg every 2 weeks
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Sirukumab 50 mg every 4 weeks
Number of subjects: 559

Group type: COMPARATOR
Intervention: Adalimumab 40 mg every 2 weeks
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Sirukumab 100 mg
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Sirukumab 50 mg
Number of subjects: 559

Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 559
Study: 27363733

Group type: EXPERIMENTAL
Intervention: Lactobacillus helveticus Lafti L10 (2 × 10^10 CFU)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 25229956

Group type: EXPERIMENTAL
Intervention: Short-term educational intervention for parents (6 sessions on children's anxiety management)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (follow-up only)
Number of subjects: 49
Study: 23756581

Group type: EXPERIMENTAL
Intervention: Grana Padano cheese containing lysozyme (30 g)
Number of subjects: 25

Group type: COMPARATOR
Intervention: TrentinGrana cheese (lysozyme-free, 30 g)
Number of subjects: 25
Study: 19834732

Group type: EXPERIMENTAL
Intervention: 12-week combined cycle interval and muscle resistance training program
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 48
Study: 18450053

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 16307690

Group type: EXPERIMENTAL
Intervention: RMABE (Rhizophora mangle aqueous bark extract)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: RMABE
Number of subjects: 32
Study: 12088916

Group type: EXPERIMENTAL
Intervention: 200 microg iodide (group A)
Number of subjects: 86

Group type: COMPARATOR
Intervention: 50 microg iodide (group B)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 86
Study: 10460558

Group type: EXPERIMENTAL
Intervention: Chlorhexidine/silver sulphadiazine‐bonded catheters
Number of subjects: 228

Group type: COMPARATOR
Intervention: Standard catheters
Number of subjects: 228
Study: 7599662

Group type: EXPERIMENTAL
Intervention: Trisequens (17 beta‐estradiol and norethindrone acetate)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Trisequens
Number of subjects: 82
Study: 2213803

Group type: EXPERIMENTAL
Intervention: Automated External Defibrillator (AED) as an adjunct to basic life support
Number of subjects: 398

Group type: COMPARATOR
Intervention: Basic life support alone
Number of subjects: 398
Study: 619237

Group type: EXPERIMENTAL
Intervention: Leg exercise (bicycle)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Leg injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abdominal injection
Number of subjects: 0
Study: 31494734

Group type: EXPERIMENTAL
Intervention: Percutaneous transesophageal gastro-tubing (PTEG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nasogastric tubing (NGT)
Number of subjects: 40
Study: 30414526

Group type: EXPERIMENTAL
Intervention: Modified Percutaneous Kyphoplasty (MPKP)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Percutaneous Kyphoplasty (PKP)
Number of subjects: 76
Study: 28858080

Group type: EXPERIMENTAL
Intervention: Acarbose + insulin
Number of subjects: 272

Group type: COMPARATOR
Intervention: Metformin + insulin
Number of subjects: 272
Study: 25234405

Group type: EXPERIMENTAL
Intervention: Bonded without primer
Number of subjects: 92

Group type: COMPARATOR
Intervention: Bonded with primer
Number of subjects: 92
Study: 24120618

Group type: EXPERIMENTAL
Intervention: High nitrate meal (220mg of nitrate derived from spinach)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low nitrate meal (control)
Number of subjects: 26
Study: 21273182

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control (no darbepoetin alfa)
Number of subjects: 74
Study: 19565731

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Yizhi Jiannao Granules
Number of subjects: 84

Group type: COMPARATOR
Intervention: Yizhi Jiannao Granules
Number of subjects: 84

Group type: COMPARATOR
Intervention: Aricept
Number of subjects: 84
Study: 17026726

Group type: EXPERIMENTAL
Intervention: Schizophrenia
Number of subjects: 1074

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1074
Study: 12651168

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical haemodynamic correction of reflux (CHIVA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Compression treatment
Number of subjects: 80
Study: 10393618

Group type: EXPERIMENTAL
Intervention: L-amino acid-based elemental formula (AAF)
Number of subjects: 18
Study: 8763898

Group type: EXPERIMENTAL
Intervention: Ornidazole
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76

Group type: COMPARATOR
Intervention: Ornidazole and Placebo
Number of subjects: 76
Study: 1909274

Group type: EXPERIMENTAL
Intervention: 3 million units of Intron‐A trice weekly for 6 months (Group A)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Dose titration according to ALT-AST values (Group B)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Prednisolone withdrawal followed by regimen A (Group C)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group: no treatment for 6 months (Group D)
Number of subjects: 75
Study: 6636797

Group type: EXPERIMENTAL
Intervention: Euphyllin retard 350 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mundiphyllin retard 225 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous Theophylline (10 mg/kg body weight over 24 hours)
Number of subjects: 0
Study: 31361726

Group type: EXPERIMENTAL
Intervention: Blood salvage and reinfusion system (OrthoPat - Group 1)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard subfascial closed suction drain (Group 2)
Number of subjects: 70
Study: 31287010

Group type: EXPERIMENTAL
Intervention: Mindful-compassion art therapy (MCAT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist-control group (no immediate intervention)
Number of subjects: 60
Study: 29187133

Group type: EXPERIMENTAL
Intervention: Lay health advisor model intervention for organ donation education delivered by trained sorority/fraternity members over a 12-month period.
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Lay health advisor model intervention for organ donation education.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Comparison group receiving education on chronic disease.
Number of subjects: 25
Study: 25412293

Group type: EXPERIMENTAL
Intervention: Injected placebo (OxyRBX) - subcutaneous saline injections daily during the placebo phase
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control - no intervention during the control phase
Number of subjects: 15
Study: 24434091

Group type: EXPERIMENTAL
Intervention: Bexarotene (75 mg/d)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 21413089

Group type: EXPERIMENTAL
Intervention: ACT and lime juice
Number of subjects: 120

Group type: COMPARATOR
Intervention: ACT alone
Number of subjects: 120
Study: 20015358

Group type: EXPERIMENTAL
Intervention: Phytalgic (fish-oil, vitamin E, Urtica dioica)
Number of subjects: 81
Study: 17014636

Group type: EXPERIMENTAL
Intervention: Intensive education program focused on dermatology and immunology for parents and children
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Intensive education program
Number of subjects: 61
Study: 15271195

Group type: EXPERIMENTAL
Intervention: Ciclopirox 1% shampoo applied once weekly
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Ciclopirox 1% shampoo applied twice weekly
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Ciclopirox 1% shampoo applied three times weekly
Number of subjects: 183

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 183
Study: 11105520

Group type: EXPERIMENTAL
Intervention: Short unfilled interval between exposures (< 500 msec for melodies; < 300 msec for pictures)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short unfilled interval between exposures
Number of subjects: 0
Study: 9950627

Group type: EXPERIMENTAL
Intervention: Migraine with aura (MA) patients
Number of subjects: 81
Study: 7995184

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei strain GG 10(10) colony-forming units twice daily for five days
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (not given lactobacilli)
Number of subjects: 42
Study: 3135047

Group type: EXPERIMENTAL
Intervention: Endoscopic injection of adrenaline
Number of subjects: 68
Study: 29871798

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS administered over the right parietal lobe for 10 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 36
Study: 28710927

Group type: EXPERIMENTAL
Intervention: Mindful breathing
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation (LKM)
Number of subjects: 88

Group type: COMPARATOR
Intervention: No-instruction condition
Number of subjects: 88
Study: 26280691

Group type: EXPERIMENTAL
Intervention: Assisted Cycling Therapy (ACT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Voluntary Cycling (VC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No Cycling (NC)
Number of subjects: 0
Study: 22632451

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0
Study: 21921250

Group type: EXPERIMENTAL
Intervention: Fluoride varnish (22,600 ppm) applied 3 times each year for 3 years
Number of subjects: 2967

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 2967
Study: 19178096

Group type: EXPERIMENTAL
Intervention: Triangular woodstick
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Round toothpick
Number of subjects: 15
Study: 16041840

Group type: EXPERIMENTAL
Intervention: Bupropion SR (100-300 mg per day for 4 weeks)
Number of subjects: 21
Study: 12031879

Group type: EXPERIMENTAL
Intervention: HKII-positive breast cancer
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Glut-1-positive breast cancer
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: FDG uptake
Number of subjects: 100
Study: 10101619

Group type: EXPERIMENTAL
Intervention: Contingency Management
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 14
Study: 7818104

Group type: EXPERIMENTAL
Intervention: Ketorolac (1 mg/kg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Acetaminophen (35 mg/kg)
Number of subjects: 50
Study: 1693396

Group type: EXPERIMENTAL
Intervention: Rice glucose polymers
Number of subjects: 16

Group type: COMPARATOR
Intervention: Corn glucose polymers
Number of subjects: 16
Study: 573007

Group type: EXPERIMENTAL
Intervention: Increased serum level of TSH
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased serum level of prolactin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ectopic production of peptides
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic change of peptides in elderly patients
Number of subjects: 0
Study: 6345178

Group type: EXPERIMENTAL
Intervention: Prazosin (1 mg twice daily)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Prazosin (highest tolerated dose 2-8 mg daily)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 15
Study: 31200437

Group type: EXPERIMENTAL
Intervention: Higher protein (HP, n = 22) - 1.2 g protein·kg‐1·d‐1
Number of subjects: 47

Group type: COMPARATOR
Intervention: Normal protein (NP, n = 25) - 0.8 g protein·kg‐1·d‐1
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups (HP and NP)
Number of subjects: 47
Study: 30045757

Group type: EXPERIMENTAL
Intervention: Medication monitor-based treatment strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 26609172

Group type: EXPERIMENTAL
Intervention: RUSF-15%
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: RUSF-33%
Number of subjects: 533

Group type: COMPARATOR
Intervention: Control
Number of subjects: 533
Study: 24461395

Group type: EXPERIMENTAL
Intervention: On-demand ibuprofen (400 mg single dose plus rescue medication)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular ibuprofen (400 mg every 6 hours for at least 24 hours)
Number of subjects: 60
Study: 22033897

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection of hyaluronic acid (HA) and contrast dye
Number of subjects: 99

Group type: COMPARATOR
Intervention: Blind injection of hyaluronic acid (HA) and contrast dye
Number of subjects: 99
Study: 19084273

Group type: EXPERIMENTAL
Intervention: Travatan Dosing Aid (DA; Alcon, Fort Worth, TX)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Self-report by patients
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Physician assessment
Number of subjects: 196
Study: 17932361

Group type: EXPERIMENTAL
Intervention: 400 microg of folic acid
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: 1,200 microg of folic acid
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: 400 microg of folic acid plus 5 mg of riboflavin
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204